Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Invested Capital: 2022-2023

Historic Return on Invested Capital for Mirum Pharmaceuticals (MIRM) over the last 1 years, with Mar 2023 value amounting to -0.84%.

  • Mirum Pharmaceuticals' Return on Invested Capital was N/A to -0.84% in Q1 2023 from the same period last year, while for Mar 2023 it was -0.84%, marking a year-over-year change of. This contributed to the annual value of -0.94% for FY2022, which is N/A change from last year.
  • Mirum Pharmaceuticals' Return on Invested Capital amounted to -0.84% in Q1 2023, which was down 5.32% from -0.80% recorded in Q4 2022.
  • Mirum Pharmaceuticals' 5-year Return on Invested Capital high stood at -0.80% for Q4 2022, and its period low was -1.22% during Q2 2022.
  • Its 2-year average for Return on Invested Capital is -0.93%, with a median of -0.86% in 2023.